Pathway Financial Advisers
ABBV icon

Pathway Financial Advisers’s AbbVie ABBV Stock Holding History

Pathway Financial Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.29M Buy
35,498
+912
+3% +$234K 2.33% 4
2026
Q2 		$8.7M Buy
34,586
+349
+1% +$75.1K 2.19% 6
2026
Q1 		$7.45M Buy
34,237
+686
+2% +$152K 2.11% 6
2025
Q4 		$7.67M Sell
33,551
-25
-0.1% -$5.7K 2.22% 5
2025
Q3 		$7.73M Buy
33,576
+1,082
+3% +$220K 2.26% 4
2025
Q2 		$6.03M Buy
32,494
+379
+1% +$70.4K 1.95% 7
2025
Q1 		$6.73M Sell
32,115
-601
-2% -$117K 2.31% 4
2024
Q4 		$5.81M Buy
32,716
+37
+0.1% +$6.8K 1.95% 7
2024
Q3 		$6.45M Sell
32,679
-238
-0.7% -$44.4K 2.92% 2
2024
Q2 		$5.62M Buy
32,917
+520
+2% +$86.1K 2.01% 7
2024
Q1 		$5.9M Sell
32,397
-1,710
-5% -$295K 2.12% 6
2023
Q4 		$5.29M Buy
34,107
+17
+0% +$2.48K 2.01% 7
2023
Q3 		$5.08M Buy
+34,090
New +$5M 2.1% 6
2023
Q1 		$5.42M Sell
34,019
-4,126
-11% -$631K 2.18% 4
2022
Q4 		$6.16M Buy
+38,145
New +$5.85M 2.5% 1

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pathway Financial Advisers's ABBV Position: Q3 2026 in Review

Pathway Financial Advisers increased its AbbVie (ABBV) stake by 2.6% in Q3 2026, buying an estimated $234K and bringing the position to 35,498 shares worth $9.29M. The position accounts for 2.33% of the portfolio, ranked #4.

Pathway Financial Advisers first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 3,494 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Pathway Financial Advisers held 35,498 shares of AbbVie worth $9.29M as of Q3 2026.
  • Pathway Financial Advisers bought 912 AbbVie shares in Q3 2026, an estimated $234K.
  • AbbVie made up 2.33% of Pathway Financial Advisers's portfolio in Q3 2026, its #4 holding.
  • Pathway Financial Advisers first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 3,494 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Pathway Financial Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.